TANIRALEUCEL

UNII:	XO25H8E4QP
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	TANIRALEUCEL
GSRS Full Record:	XO25H8E4QP i

ALLOGENEIC UMBILICAL CORD BLOOD-DERIVED, CULTURE-EXPANDED NATURAL KILLER CELLS
Allogeneic natural killer (NK) cells derived from CD34+ human placental stem/progenitor cells. The cells are expanded and differentiated in the presence of cytokines including thrombopoietin, SCF, Flt3 ligand, IL-7, IL-15 and IL-2 to generate the NK cell population. Cells (on average >95% of the cells) are CD56+/CD3- and have detectable levels of CD94, NKG2D and CD16. The cells secrete IFN-γ, perforin and granzyme B, and have cytolytic activity against human tumor cell lines.
PNK-007
TANIRALEUCEL [USAN]
Taniraleucel
Taniraleucel [WHO-DD]
taniraleucel [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

TANIRALEUCEL

Synonyms and Mappings

Resources